Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes ; volume:14 ; number:1 ; day:5 ; month:8 ; year:2013 ; pages:1-6 ; date:12.2013
BMC pharmacology & toxicology ; 14, Heft 1 (5.8.2013), 1-6, 12.2013
- Urheber
-
Urien, Saik
- Beteiligte Personen und Organisationen
-
Bardin, Christophe
Bader-Meunier, Brigitte
Mouy, Richard
Compeyrot-Lacassagne, Sandrine
Foissac, Franz
Florkin, Benoît
Wouters, Carine
Neven, Bénédicte
Tréluyer, Jean-Marc
Quartier, Pierre
SpringerLink (Online service)
- DOI
-
10.1186/2050-6511-14-40
- URN
-
urn:nbn:de:1111-2016071827013
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Urien, Saik
- Bardin, Christophe
- Bader-Meunier, Brigitte
- Mouy, Richard
- Compeyrot-Lacassagne, Sandrine
- Foissac, Franz
- Florkin, Benoît
- Wouters, Carine
- Neven, Bénédicte
- Tréluyer, Jean-Marc
- Quartier, Pierre
- SpringerLink (Online service)
Ähnliche Objekte (12)
Autoinflammatory gene polymorphisms and susceptibility to UK juvenile idiopathic arthritis
Autoinflammatory syndromes: diagnosis and management
Imaging findings of juvenile idiopathic arthritis and autoinflammatory diseases in children
Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases
Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis
Haptoglobin in Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis-associated uveitis
Ultrasound in juvenile idiopathic arthritis
Juvenile onset autoinflammatory disease due to a novel mutation in TNFAIP3 (A20)
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies
Autoinflammatory gene polymorphisms and susceptibility to UK juvenile idiopathic arthritis
Autoinflammatory syndromes: diagnosis and management
Imaging findings of juvenile idiopathic arthritis and autoinflammatory diseases in children
Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases
Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis
Haptoglobin in Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis-associated uveitis
Ultrasound in juvenile idiopathic arthritis
Juvenile onset autoinflammatory disease due to a novel mutation in TNFAIP3 (A20)
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies
Autoinflammatory gene polymorphisms and susceptibility to UK juvenile idiopathic arthritis
Autoinflammatory syndromes: diagnosis and management
Imaging findings of juvenile idiopathic arthritis and autoinflammatory diseases in children
Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases
Development and validation of juvenile autoinflammatory disease multidimensional assessment report (JAIMAR)
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis
Haptoglobin in Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis-associated uveitis
Ultrasound in juvenile idiopathic arthritis
Juvenile onset autoinflammatory disease due to a novel mutation in TNFAIP3 (A20)